Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer

Yanjing Li, Yiping Shen, William Butler, Lingfan Xu, Yan Chang, Kefeng Lei, Hong Zhang, Yinglu Zhou, Allen C Gao, Qingfu Zhang, Daniel G Taylor, Donghui Cheng, Suzette Farber-Katz, Rachid Karam, PhD, Tyler Landrith, Bing Li, Sitao Wu, Vickie Hsuan, Qing Yang, Hailiang Hu, Xufeng Chen, Melissa Flowers, Shannon J McCall, John K Lee, Bryan A Smith, Jung Wook Park, Andrew S Goldstein, Owen N Witte, Qianben Wang, Matthew B Rettig, Andrew J Armstrong, Qing Cheng, Jiaoti Huang